Labiotech.eu

blood cancer disease model, multi-omics, CAR-T, oncology

News and Trends 28 May 2016

It’s Blood Cancer Day, how is Biotech fixing it?

Today is the World Blood Cancer Day, an event to show solidarity to patients and raise awareness for the need of better therapies to treat these cancers – which are still often deadly. Blood cancers can affect different type of cells in the blood. Because these cells are so close to the circulatory and immune system, […]

May 28, 2016 - 4 minutesmins - By Denise Neves Gameiro

News and Trends 27 May 2016

Biotech of the Week: Pharnext, developing next level drugs against Alzheimer’s and Parkinson’s disease

The Scandinavian charm is wonderful but this week we are (finally) heading back to Central Europe. Do I really need to say what happens in Paris? We all know that: The Eiffel Tower, the Louvre, the pretty sights, la Seine and it’s also the cité de l’amour. However, it is also where Pharnext, our Biotech of the Week, is […]

May 27, 2016 - 2 minutesmins - By Joachim Eeckhout

labiotech refresh startup conference may berlin biotech startup highlights

News and Trends 27 May 2016

So that was Labiotech Refresh! Here are the conference Highlights

So after months of planning our first biotech conference, it’s kind of surreal to think it’s actually over. For now, anyway! Here’s a recap of the day; speakers, panels, audience and the team, as we put together the premier of Labiotech’s Conference series – Labiotech Refresh. Philip and Joachim during the opening speech. It all kicked […]

May 27, 2016 - 5 minutesmins - By Dani Bancroft

qiagen therawis diagnostics chemotherapy tnbc

News and Trends 26 May 2016

Qiagen partners up for Novel Diagnostic against Breast Cancer

Qiagen is partnering up with Therawis to develop a diagnostic test to predict how effective an aggressive chemotherapy will be in patients with high risk breast cancer. A giant in molecular diagnostics, Qiagen is now working in a new diagnostic test that could help guide the treatment of breast cancer. Now, Qiagen has partnered with […]

May 26, 2016 - 2 minutesmins - By Denise Neves Gameiro

News and Trends 26 May 2016

French T-cell Expert restarts trial for Crohn’s after Manufacturing Hiccup

TxCell is restarting its trial for Ovasave, an autologous T-cell therapy, with a new manufacturing partner. This therapy is targeting Crohn’s disease which does not respond to current treatments. TxCell is based in Sophia-Antipolis (France) and is developing immunotherapies based on a type of T-cells that have anti-inflammatory properties – regulatory T-lymphocytes (Tregs). Its most advanced programme is in refractory Crohn’s […]

May 26, 2016 - 2 minutesmins - By Denise Neves Gameiro

News and Trends 26 May 2016

GSK teams up with US Money to found new Biotech

GSK and Avalon Ventures are having success with the Biotechs created under their collaboration. Sitari Pharmaceuticals and Silarus Therapeutics have achieved their first milestones, and there’s a 8th Biotech in the making. As part of its innovation hunting in the US, English big Pharma GSK had struck a collaboration with Avalon Ventures and formed an ‘undercover incubator’ of sorts. […]

May 26, 2016 - 2 minutesmins - By Denise Neves Gameiro

bavarian nordic imvamune smallpox hiv dermatitis

News and Trends 24 May 2016

Danish ‘safer’ vaccine for Smallpox gets US order worth €90M

Bavarian Nordic will receive €90M from the US’ BARDA for its nonreplicating smallpox vaccine – which can be administered to people with conditions like HIV. Bavarian Nordic is one of the Copenhagen-based Biotechs you need to know which is developing cancer immunotherapies and vaccines against infectious diseases. Its infectious disease programme is based on their vaccine technology which uses an […]

May 24, 2016 - 2 minutesmins - By Denise Neves Gameiro

virtiuakl biotech cloud lab robert thong industry emerald

News and Trends 23 May 2016

To Be – or Not To Be, a Virtual Biotech?

Many new biotechs start off as virtual companies. But at each stage of development, you always end up asking whether you should stay virtual or build your own in-house wet labs. What are the pros and cons of being virtual? And is there a more pragmatic “semi-virtual” approach? Pros and Cons of being Virtual Biotechs […]

May 23, 2016 - 5 minutesmins - By Dani Bancroft

international green week monsanto gmo bayer farmer protest acquisition offer biotech

News and Trends 23 May 2016

Bayer offers Big Buy out for the infamous Monsanto. Shareholders are not pleased…

Yes, everyone is talking about how Germany’s Pharma giant Bayer has made a $62 billion offer for the infamous chemicals conglomerate Monsanto. And not many like it. Bayer’s products mostly consist of human and veterinary pharmaceuticals, consumer healthcare products, agricultural chemicals, biotechnological products, and high value polymers. Monsanto on the other hand is notorious for its agricultural chemicals, GMOs […]

May 23, 2016 - 3 minutesmins - By Dani Bancroft

News and Trends 23 May 2016

Irish NASH drug will also be investigated for Major Lung Diseases

DS Biopharma was already studying one of its bioactive lipids for non-alcoholic steatohepatitis (NASH). The candidate will now also target chronic obstructive pulmonary disease (COPD). Headquartered in Dublin (Ireland), DS Biopharma is working on new medicines for medical unmet needs, such as fibrosis. This development of fibrous tissue can affect the lungs, liver or heart. DS has […]

May 23, 2016 - 2 minutesmins - By Denise Neves Gameiro

wellcome trust sanger cambridge Ebola epidemic quarantine global transmission

News and Trends 23 May 2016

Even after Quarantine, Ebola still transmitted by Breastfeeding and Sex

Researchers from University of Cambridge and the Wellcome Trust Sanger Institute have discovered that Ebola can still be transmitted through sex and breastfeeding after quarantine – causing ‘flare-ups’ even though the epidemic has ended. Without effective vaccines or treatments for Ebola infection, the 2014’s outbreak in West Africa was contained due to public health measures. These […]

May 23, 2016 - 3 minutesmins - By Denise Neves Gameiro

precision medicine innventis autoimmune inflammation

News and Trends 20 May 2016

This Israel-based Biotech startup is currently raising €17M to enable Precision Medicine

InnVentis is aiming big in the field of precision medicine. With novel molecular diagnostics and big data, it wants to tackle complicated conditions like Rheumatoid Arthiritis. Just starting out, InnVentis is an Israeli Biotech founded by Thomas Wilckens, a German expert in precision medicine originally from Munich. He and his team decided to move to Israel for financial reasons […]

May 20, 2016 - 3 minutesmins - By Denise Neves Gameiro

Knowledge hub

Categories

The top biotech deals of March 2025

The biggest biotech funding rounds in March 2025

Approaches

Therapeutic areas

Join the webinar: AI in antibody discovery - from in silico analysis to AI-enabled data management

Beyond amyloid: The search for the next big thing in Alzheimer’s treatment

R&D

BD

World biotech leaders

Connect with decision-makers and researchers worldwide for collaborative opportunities

Company

Join Us

Subscribe to our newsletter

Advertise with us

The top biotech deals of March 2025

The biggest biotech funding rounds in March 2025

Join the webinar: AI in antibody discovery - from in silico analysis to AI-enabled data management

Beyond amyloid: The search for the next big thing in Alzheimer’s treatment

Connect with decision-makers and researchers worldwide for collaborative opportunities

Subscribe to our newsletter

Advertise with us

It’s Blood Cancer Day, how is Biotech fixing it?

Biotech of the Week: Pharnext, developing next level drugs against Alzheimer’s and Parkinson’s disease

So that was Labiotech Refresh! Here are the conference Highlights

Qiagen partners up for Novel Diagnostic against Breast Cancer

French T-cell Expert restarts trial for Crohn’s after Manufacturing Hiccup

GSK teams up with US Money to found new Biotech

Danish ‘safer’ vaccine for Smallpox gets US order worth €90M

To Be – or Not To Be, a Virtual Biotech?

Bayer offers Big Buy out for the infamous Monsanto. Shareholders are not pleased…

Irish NASH drug will also be investigated for Major Lung Diseases

Even after Quarantine, Ebola still transmitted by Breastfeeding and Sex

This Israel-based Biotech startup is currently raising €17M to enable Precision Medicine

Subscribe to our newsletter to get the latest biotech news!

The top biotech deals of March 2025

The biggest biotech funding rounds in March 2025

Join the webinar: AI in antibody discovery - from in silico analysis to AI-enabled data management

Beyond amyloid: The search for the next big thing in Alzheimer’s treatment

Connect with decision-makers and researchers worldwide for collaborative opportunities

Subscribe to our newsletter

Advertise with us

The top biotech deals of March 2025

The biggest biotech funding rounds in March 2025

Join the webinar: AI in antibody discovery - from in silico analysis to AI-enabled data management

Beyond amyloid: The search for the next big thing in Alzheimer’s treatment

Connect with decision-makers and researchers worldwide for collaborative opportunities

Subscribe to our newsletter

Advertise with us

Subscribe to our newsletter

Get the latest biotech news directly to your inbox!

Newsletter Signup - Footer

Subscribe to our newsletter to get the latest biotech news!